WHERE THERAPIES GO VIRAL Trademark
Trademark Overview
On Thursday, September 25, 2025, a trademark application was filed for WHERE THERAPIES GO VIRAL with the United States Patent and Trademark Office. The USPTO has given the WHERE THERAPIES GO VIRAL trademark a serial number of 99413260. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, April 30, 2026. This trademark is owned by Vyriad, Inc.. The WHERE THERAPIES GO VIRAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; Research and development of bio-pharmaceuticals for the treatment of cancer; Medical and scientific research in the fields of genetics and oncology; Research and development of technology in the fields of stem cells and stem cell therapy; Development of therapeutics and cell therapies; Scientific research and development of cell therapies, namely, chimeric antigen receptor T-cells (CAR-T) to cure solid tumor cancers and other cancers; Medical and scientific research services in the fields of genetics, cell therapy, oncology, immuno-oncology
General Information
| Serial Number | 99413260 |
| Word Mark | WHERE THERAPIES GO VIRAL |
| Filing Date | Thursday, September 25, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, April 30, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 19, 2026 |
Trademark Statements
| Goods and Services | Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; Research and development of bio-pharmaceuticals for the treatment of cancer; Medical and scientific research in the fields of genetics and oncology; Research and development of technology in the fields of stem cells and stem cell therapy; Development of therapeutics and cell therapies; Scientific research and development of cell therapies, namely, chimeric antigen receptor T-cells (CAR-T) to cure solid tumor cancers and other cancers; Medical and scientific research services in the fields of genetics, cell therapy, oncology, immuno-oncology |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 25, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, May 7, 2024 |
| First Use In Commerce Date | Tuesday, May 7, 2024 |
Trademark Owner History
| Party Name | Vyriad, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rochester, MN 55901
US |
Trademark Events
| Event Date | Event Description |
| Thursday, September 25, 2025 | NEW APPLICATION ENTERED |
| Thursday, September 25, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 25, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, February 2, 2026 | ASSIGNED TO EXAMINER |
| Monday, February 2, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, February 2, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, February 2, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 7, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 7, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 7, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 24, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
